Target
Cyclin Dependent Kinase 6
2 abstracts
Abstract
Comparison of antitumor efficacy of first-line palbociclib, ribociclib, or abemaciclib in patients with HR+/HER2- aBC: Results of the multicenter, real-world, Italian study PALMARES-2.Org: IRCCS Policlinico S. Matteo, Dip Scienze Medico Chirurgiche Medicina, ICS Maugeri IRCCS, Ospedale di Mirano Dolo, ASST Fatebenefratelli Sacco,
Abstract
Evaluation and treatment response in patients with hormone receptor-positive, HER2 low metastatic breast cancer: A single center retrospective analysis.Org: Henry Ford Hospital, Detroit, MI,